2-Isopropyl-2-phenyl-5-(N-methyl-2-phenylethylamino)-valeronitrile derivatives and processes for their preparation
申请人:SPOFA
Spojené Podniky Pro Zdravotnickou Vyrobu
公开号:EP0257768A1
公开(公告)日:1988-03-02
2-Isopropyl-2-phenyl-5-1N-methyl-2-phenylethylaminol- valeronitrile derivatives of the general formula I
wherein R is a methyl, chlorine, bromine, C1 to C4 alkoxyl or methylthio group, preferably administered in the form of soluble acid addition salts, notablythe 2-methylphenyl analog as its hydrochloride, possess significant calcium-antagonistic and cardiac antiarrythmic activity.
Preparation is by alkylation of the corresponding butyroni- triie derivative (obtained from the respective substituted benzyicyanide by alkylation with isopropylbromide) by 3,3-diethoxypropylchloride, subsequent acidic hydrolysis of the 5,5-diethoxy-2-isopropyl-2-phenylvaleronitrile derivative obtained to the appropriate aldehyde, and reductive alkylation of this aldehyde with N-methylhomoveratrylamine by catalytic hydrogenation over a platinum or palladium catalyst or chemical reduction using formic acid. The resulting base is optionally neutralized with a pharmaceutically acceptable organic or inorganic acid, e.g. hydrochloric or fumaric acid, into the corresponding acid addition salt.
通式 I 的 2-异丙基-2-苯基-5-1N-甲基-2-苯乙基氨基戊腈衍生物,其中 R 是甲基、氯、溴、C1 至 C4 烷氧基或甲硫基。
其中 R 是甲基、氯、溴、C1 至 C4 烷氧基或甲硫基,最好以可溶性酸加成盐的形式给药,特别是 2-甲基苯基类似物盐酸盐,具有显著的钙拮抗剂和抗心律失常活性。
制备方法是用 3,3-二乙氧基丙基盐酸盐烷基化相应的丁腈三酸衍生物(从各自取代的苄基氰化物中用异丙基溴烷基化得到),然后酸性水解 5、5-二乙氧基-2-异丙基-2-苯基戊腈衍生物的酸性水解,得到相应的醛,然后通过铂或钯催化剂上的催化氢化作用或甲酸的化学还原作用,将该醛与 N-甲基高藜芦胺还原烷基化。得到的碱可选择与药学上可接受的有机酸或无机酸(如盐酸或富马酸)中和,生成相应的酸加成盐。